Westlake Village-based Turn Therapeutics, a clinical-stage dermatology company developing novel therapies for inflammatory skin diseases, announced it has entered into a growth capital loan facility with Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, for up to $25 million. Announced March 24, the facility includes an initial $7 million tranche funded…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
